Next Article in Journal
Freeze Tolerance in Sculpins (Pisces; Cottoidea) Inhabiting North Pacific and Arctic Oceans: Antifreeze Activity and Gene Sequences of the Antifreeze Protein
Next Article in Special Issue
Inclusion Complexes of β and HPβ-Cyclodextrin with α, β Amyrin and In Vitro Anti-Inflammatory Activity
Previous Article in Journal
CRISPR/Cas9-Mediated Knock-Out of dUTPase in Mice Leads to Early Embryonic Lethality
Previous Article in Special Issue
Influence of Monoterpenes in Biological Activities of Nectandra megapotamica (Spreng.) Mez Essential Oils
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomolecules
Volume 9
Issue 4
10.3390/biom9040138
biomolecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Essential Oils and Isolated Terpenes in Nanosystems Designed for Topical Administration: A Review

by
Sheila P. de Matos
1,
Helder F. Teixeira
1,
Ádley A. N. de Lima
2,
Valdir F. Veiga-Junior
3 and
Letícia S. Koester
1,*
1
Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Av. Ipiranga, 2752, Porto Alegre 90610-000, Brazil
2
Programa de Pós-Graduação em Ciências Farmacêuticas, Departamento de Farmácia, Universidade Federal do Rio Grande do Norte, Av. General Cordeiro de Farias, s/n, Petrópolis, Natal 59012-570, Brazil
3
Departamento de Engenharia Química, Instituto Militar de Engenharia, Praça Gen. Tibúrcio, 80, Praia Vermelha, Urca, Rio de Janeiro 22290-270, Brazil
*
Author to whom correspondence should be addressed.
Biomolecules 2019, 9(4), 138; https://doi.org/10.3390/biom9040138
Submission received: 8 March 2019 / Revised: 1 April 2019 / Accepted: 2 April 2019 / Published: 5 April 2019
(This article belongs to the Special Issue Evaluation and formulation of Bioactive Terpenes)
Browse Figures
Versions Notes

Abstract

:
Essential oils are natural products with a complex composition. Terpenes are the most common class of chemical compounds present in essential oils. Terpenes and the essential oils containing them are widely used and investigated by their pharmacological properties and permeation-enhancing ability. However, many terpenes and essential oils are sensitive to environmental conditions, undergoing volatilization and chemical degradation. In order to overcome the chemical instability of some isolated terpenes and essential oils, the encapsulation of these compounds in nanostructured systems (polymeric, lipidic, or molecular complexes) has been employed. In addition, nanoencapsulation can be of interest for pharmaceutical applications due to its capacity to improve the bioavailability and allow the controlled release of drugs. Topical drug administration is a convenient and non-invasive administration route for both local and systemic drug delivery. The present review focuses on describing the current status of research concerning nanostructured delivery systems containing isolated terpenes and/or essential oils designed for topical administration and on discussing the use of terpenes and essential oils either for their biological activities or as permeation enhancers in pharmaceutic formulations.

1. Introduction

Essential oils (EO) are natural products extracted by hydrodistillation from plant materials, composed by small, volatile, and fairly hydrophobic molecules [1,2,3]. The functions of EO in plant organisms seem to be related to environmental interactions and protection of the plant against predators and pathogens [1,4,5]. In the industry, essential oils are materials of great interest with a wide range of possible applications in the nutritional, agricultural, cosmetic, and pharmaceutical fields [6,7], due to their broad spectra of biological activities such as antimicrobial, repellent, analgesic, anti-inflammatory activity, and many others [1,2]. Essential oils can be extracted from plant matrices using different techniques classified as classical/conventional (that use water distillation by heat as a means to extract the whole volatile material) and innovative/advanced (which focus on the improvement of selectivity in extraction efficiency by reducing extraction time, use of energy, solvent, and CO2 emissions) [1].
Terpenes and terpenoids (the oxygenated derivatives of terpenes [2]) are the chemical compounds representing the majority of molecules in essential oil composition [8]. This class of molecules is characterized by the combination of isoprene units (C5H8). Terpenes can be classified according to the number of isoprene units in their structure (e.g., hemiterpenes are formed by one isoprene unit, monoterpenes are formed by two isoprene units, sesquiterpenes by three isoprene units, and diterpene formed by four units) [2,8]. Smaller terpenes, up to three isoprene units, are highly volatile, and the volatility decreases with an increased number of isoprene units [9]. Many biological activities of terpenes and terpenoids are described in the literature, being this class of molecules a valuable source of therapeutic agents with pharmaceutical applications, such as anti-inflammatory [10], wound healing [11], antineoplastic applications [12,13,14]. In addition, some compounds of the class are widely investigated and reported as penetration enhancers for percutaneous drug delivery, being used as excipients in the preparation of nanostructured systems [7,8,15]. Smaller terpenes are usually thermolabile and susceptible to volatilization and degradation, mainly by oxidation and isomerization [6,16].
The topical administration of drugs consists in the localized administration of formulations to an organism, comprising dermal and mucosal administrations (e.g., ocular, vaginal, nasal, and rectal routes). Among those, the most widely employed is the cutaneous route, which may be attributed to the easiness of access compared to other topic routes [17]. When applied to the skin, a drug delivery system can be considered dermal (when the targeting site of the drug is the skin) or transdermal (when the drug needs to pass through skin layers in order to reach its target); for mucosal tissue administration, delivery can be mucosal and transmucosal [18]. Many issues concerning these delivery routes are described in the literature, such as the resistance to diffusion through the skin and mucosae when aiming towards transdermal or transmucosal delivery and the reduced contact of the formulation with mucosal tissues due to mucus and, thus, reduced drug bioavailability [19,20].
Encapsulation of essential oils in micro or nanometric systems is an interesting strategy to provide better stability to the volatile compounds and protect them against environmental factors that may cause chemical degradation [2,6]. In addition, the encapsulation in nanometric systems may improve the bioavailability and bioefficacy of formulations as a result of cellular absorption and provide controlled release of bioactive compounds [3,21]. Special nanostructured systems have been designed intending topical administration as approaches to overcome the drawbacks inherent to these administration routes, such as mucoadhesive systems that prolong the contact with mucosae and systems that favor the passage of the drug trough skin or mucosal tissue layers [20,22]. Molecular encapsulation through complexation with cyclodextrins is another strategy employed to improve the stability of essential oil components, avoid volatilization (and, consequently, prolonging contact,) and enhance permeation of the bioactive molecules [23].
In recent decades, the interest in nanotechnological approaches and use of natural products have raised great attention in the search and development of drug delivery systems. The present review intends to assess the panorama of research using nanostructured delivery systems containing essential oils and/or their isolated terpenes/terpenoids as bioactive compounds and/or excipients for topical administration routes.

2. Literature Survey

A literature survey was carried out in three different databases: Embase, Scopus, and Pubmed. Initially, all results found until 31 December 2018 were considered, without limiting the search period before this date. The search terms used were a combination of words related to nanostructured systems “AND” terpenes/essential oils “AND” topical administration route. All classes of terpenes were included, not only low-volatile terpenes, as well as all topical administration routes, which comprise cutaneous and mucosal administration. Database search lines can be found in Supplementary Materials, Table S1.
The number of results obtained using Scopus were 87, those from Embase were 365, and those from PubMed were 64. Among those results, only research articles in English were considered for data screening. Also, duplicates were disregarded. In addition, reference lists of papers were screened to detect research papers which did not appear in the database research but might fulfill the acceptance criteria (Figure 1). Afterwards, the papers were screened and selected if meeting the following acceptance criteria:
  • Original research data.
  • Use of essential oil containing terpenes and/or isolated terpenes in nanostructured systems or cyclodextrins.
  • Formulations for topical administration.
Finally, 82 papers were selected for further data extraction. Studies were sorted by year of publication in order to visualize the evolution of research in this field over the years (Figure 2). The first report dated from 1989 and was by Saettone et al. [24], who studied the complexation of the diterpene forskolin with cyclodextrin for ocular administration. The number of publications has gradually grown over the years, indicating an increasing interest in the topic.
Data concerning the essential oil or terpene used, encapsulation system, nanosystem preparation technique, administration route of formulation, and use of EO/terpene as bioactive compounds or excipients were extracted from the selected papers and compiled in Table 1 and Table 2 in order to ease the access to the extracted data, which are further discussed in the following sections of this review.

3. Discussion

3.1. Topical Administration Routes

Topical drug administration can be described as the localized application of a pharmaceutical dosage form and comprises both dermal and mucosal administration [19,20]. In Figure 3, the different sites of administration for nanosystems containing isolated terpenes and/or EO are shown. It can be noticed that among the study formulations containing nanoencapsulated EO and/or terpenes, dermal and transdermal administration represent nearly 90% of the administration routes, which can be attributed to the non-invasiveness, convenience, and painless qualities of this type of administration.
Dermal administration of nanostructured systems containing terpenes and EO is, in general, mainly used as a treatment for conditions localized on the skin surface, such as for wound healing, and to vehiculate anti-inflammatory, antimicrobial, and repellent agents. On the other hand, transdermal delivery is employed in cases where the bioactive compound needs to reach deeper layers of the skin or even the systemic circulation, such as for anesthetic, antihypertensive, and antidiabetic drugs (Table 1 and Table 2).
Mucosal administration (ocular, nasal, oral, vaginal) still represents a challenging route due to the presence of mucus, lacrimal fluids, and saliva, which can impair the bioavailability of the bioactive compound [19]. However, it is possible to foresee the development of mucoadhesive formulations as means to overcome these limitations.

3.2. Role of Essential Oil and/or Terpenes in the Formulations

In order to understand the applications of EO containing terpenes and/or isolated terpenes encapsulated in nanosystems intended for topical administration, the studies were divided between those in which EO/terpenes were used as excipient and those in which they were used as bioactive compounds. Of 82 studies, 56 employed terpenes/EO as bioactive ingredients in formulations, whereas 29 reported terpenes/EO as excipients in formulations (Figure 4). Zhang et al. [38] reported both bioactive (anti-inflammatory) and penetration-enhancing activities of the terpene Paeoniflorin encapsulated in glycerosomes. Also, Castangia et al. [90] described the preparation of permeation-enhancing vehicles containing Santolina insularis EO as an antimicrobial and permeation enhancer for percutaneous drug delivery.
Many biological and pharmacological activities of EO and terpenes are well described in the literature, and the interest in their use as bioactive ingredients in pharmaceutical formulations has been rising recently, alongside with the seek for natural products as alternatives for drug development [1,5].
In general, the use of terpenes as excipients aims to increase the permeation of the active compound through skin layers, since terpenes are extensively cited in the literature as permeation enhancers [7,15,102]. The application of terpenes as excipients is further discussed in Section 3.2.2.

3.2.1. Nanostructured Systems Used in the Encapsulation of Terpenes and Essential Oils as Bioactive Ingredients

The therapeutic potential of terpenes and EO containing terpenes is well known. Biological activities such as bactericidal, fungicidal, antioxidant, virucidal, and antineoplastic activities are well recognized [3,5,103]. There is a number of good reviews in the literature that list the variety of nanostructured systems and preparation techniques employed in the encapsulation of EO in nanostructures systems [1,2,104], but none focused on terpenes. Among the studies listed in Table 1 and Table 2, the most widely investigated biological activities upon nanoencapsulation of essential oils and isolated terpenes were the anti-inflammatory activity of essential oils and oil resins containing terpenes, such as plai oil [93], Copaifera multijuga oil [89,97], Nigella sativa EO [78], and of the isolated terpenes triptolide [41,65,71,73], sericoside [72], thymol [10] and oleanoic and ursolic acids [53], as well as the wound healing properties of Syzygium aromaticum EO [83], Melaleuca alternifolia EO [91], triterpenes from Centella asiatica extract [85], madecassoside [105], asiaticoside [48], astragaloside IV [59], and hyperforin [11]. Also, the nanoencapsulation of the well-established taxane antineoplastic drugs paclitaxel [14] and docetaxel [13,35] were studied for topical administration.
The systems can be divided according to their composition of polymers and lipids [21]. Polymer-based systems can be constituted by natural, synthetic, and semisynthetic polymers and comprise systems such as nanocapsules (NC), nanoparticles (NP), nanofibers (NF), and nanogels (NG). On the other hand, the lipid-based systems, namely, nanoemulsions (NE), liposomes (LS), solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), and vesicular systems (VS) which comprehend ethosomes, phytosomes, niosomes, glycerosomes, and invasomes (IV) [106], are formed by lipids [104]. In addition, molecular complexation of terpenes with cyclodextrins is reported in the literature as a strategy for essential oil and natural products nanoencapsulation [2,107].
Encapsulation in nanometric systems is widely described in the literature as an approach to overcome many disadvantages concerning essential oils by providing protection against environmental factors that can cause chemical degradation and avoiding volatilization of EO components. In addition, nanoencapsulation can improve the bioavailability, allow controlled drug release, and enable the passage of the bioactive compounds through biological barriers [21]. Patel et al. [62] compared the cutaneous permeation of the sesquiterpene Hurpezine A from transdermal gels after encapsulation in three different systems, i.e., microemulsion (ME), SLN, and NLC, and the in vivo activity in an experimental mice model of induced amnesia. The ME formulation presented the highest cumulative permeated amounts, followed by NLC and SLN. The in vivo experiments presented no significant difference between the three formulations, but positive outcomes when compared to the negative control. In other study of comparison between different nanostructured systems, Flores et al. [96] investigated nanocapsule suspensions and nanoemulsions containing tea tree oil against in in vitro onychomycosis models. Although both nanometric systems presented better antifungal activity compared to the coarse emulsion containing tea tree oil, the nanocapsule formulation was more effective against the microorganism. This may be attributed to the polymer barrier that prevents the volatilization of bioactive compounds as well as the capacity of the aqueous suspension to hydrate the tissue and therefore enhance the penetration of nanostructures.
Also, the complexation with cyclodextrins can be an interesting alternative, since it is reported to provide protection against environmental factors, improve stability, avoid volatilization of EO components, improve oral bioavailability, and reduce mucosal irritation [23]. In addition, cyclodextrins are described as safe options to enhance the permeation of molecules through the skin and mucosae [2,15,108]. The complexation of essential oils and isolated terpenes with cyclodextrins has been reported in the literature and reviewed [23,109,110]; however, the majority of investigations concerning complexes between cyclodextrins and essential oils or isolated terpenes for pharmaceutical applications are limited to oral administration, with few studies focusing on topical administration, and no reviews found in the literature covering this subject specifically. Rode et al. [72] studied the influence of cyclodextrin complexation on the percutaneous penetration in pig skin of the triterpenoid sericoside from a Terminalia sericea extract. The formulation containing the sericoside from the extract complexed with γ-cyclodextrin increased the percutaneous penetration 2.6 times when compared to an ethanolic solution of sericoside.
As illustrated in Figure 5, a variety of different nanostructured systems are used in the encapsulation of EO and terpenes. It can be noticed that lipid-based nanosystems are used in 67% of the formulations reported, which may be attributed to their low toxicity.
Although various preparation techniques of nanostructured systems are extensively described in the literature [1,2,104], it is important to pay attention to the preparation technique in terms on its influence on EO/terpene stability, because of their sensitivity to heat and pressure. In this context, the quantification of chemical markers of EO or terpenes is essential, especially in cases where they play a role as bioactive compounds, in order to ensure the integrity of EO/terpene content in the final formulation and, thus, the safety and efficacy of the final product [104].

3.2.2. Terpenes as Excipients in Formulations for Topical Administration

Transdermal drug delivery represents a convenient route of administration for systemic action due to its non-invasive characteristic [102,111]. However, it is limited by the ability of the drug to permeate through the skin layers, especially the stratum corneum (SC). The use of penetration enhancers is a promising strategy to broaden the range of drugs eligible for transdermal delivery [112].
Permeation enhancers are used as excipients in formulations and are capable of facilitating the passage of a drug through the skin. Besides their biological activities, essential oils and isolated terpenes have been described as promising permeation enhancers for transdermal drug delivery. They can enhance the passage of drugs through the skin by interacting with stratum corneum lipids and modifying the solubility characteristics of these lipids, facilitating drug partitioning towards deeper layers of the skin [7,8,15,102]. Furthermore, terpenes are considered safer than other permeation enhancers from a toxicological point of view, with some terpenes being included in the list of Generally Recognized as Safe (GRAS) compounds from the US FDA (United States Food and Drug Administration) [8].
The nanostructured systems in which terpenes are used as excipients are illustrated in Figure 6. The majority of systems are based on vesicular structures (LS, I,V and permeation-enhancing vehicles (PEV)), with the invasomes representing 27% of the nanostructured systems reported, followed by liposomes and nanoemulsions (20%).
Invasomes (also found in the literature as invasosomes) are special drug delivery systems that contain terpenes and are the most recurrent among the formulations of nanosystems using terpenes as excipients (Figure 6). They are, by definition, vesicular systems consisting of terpenes, ethanol, and phospholipids as fundamental raw materials and present elasticity and deformability, which favors penetration across skin layers, and thus they work as penetration-enhancing vehicles [113]. According to the data presented in Table 1 and Table 2, the terpenes used in the formulation of invasomes are limonene, cineole, fenchone, citral, and beta-citronellene; all of them are monoterpenes or monoterpenoids (Figure 7).
Kamran et al. [45] studied the preparation of invasomes using beta-citronellene as a permeation enhancer for transdermal delivery of the antihypertensive olmesartan and observed an increase in the bioavailability of olmesartan from invasomes in Wistar rats compared to the control. Incorporation of isradipine, also an antihypertensive agent, in invasomes containing beta-citronellene was investigated by Qadri et al. [42], who showed a decrease of 20% of blood pressure in rats. The permeation of rhodamine B invasomes through rat skin was evaluated by confocal laser spectroscopy, and fluorescence was detected at a depth of 171.18 mm in the skin. A series of studies focused on the encapsulation of temoporfin in invasomes, aiming to improve its penetration through the skin using several different proportions of cineole, citral, and d-limonene. The findings indicated that the optimal amount of terpenes in formulations should be 1% (v/v), and the formulation containing 1% of cineole alone led to higher permeation of the drug to deeper layers of the skin compared to mixtures of the three terpenes in varied proportions and limonene and citral alone [68,69,70]. El-Nabarawi et al. [25] prepared dapsone-loaded invasomes for acne treatment, containing different terpenes (limonene, cineole, citral, or fenchone) in varied concentrations in a full factorial design study and compared drug deposition in vivo of optimized formulations with dapsone solution, finding a 2.5-fold increase in dapsone deposition with the invasomes formulation.

3.3. Safety of Essential Oils and Terpenes in Topical Administration

One important concern is the safety of the use of essential oils and terpenes in topical formulations. Although a number of essential oils and terpenes are considered GRAS [8], few studies investigated the safety of these compounds in topical application. Lalko and Api [114] investigated the skin irritancy of essential oils and their isolated compounds, concluding that, in many cases, there is a potential induction of sensibilization upon exposure to these compounds. Some terpenes, as described in previous sections of this review, are used as permeation enhancers in drug delivery systems. They are considered non-toxic, nonirritant, and, therefore, a safe option for permeation enhancement [115].

3.4. Sustainability

In recent decades, the efforts to reduce the environmental impact of chemical compounds and develop green chemistry have been growing. Terpenes and essential oils comprise a renewable source of chemical compounds and have been already described in the literature as “greener” alternatives to pesticides [116] and solvents [117]. Concerning the preparation of nanostructured systems, essential oils and terpenes can be used as more sustainable additives, being able to substitute organic solvents in the preparation of nanocapsules [118] and in the synthesis of metallic nanoparticles [119]. Also, effort has been made for the development of essential oil extraction techniques with no or less solvent and energy use without quality loss [120]. When observing the 12 principles of Green Chemistry [121], it is possible to see that the use of terpenes and essential oils may have some positive effects, since, as aforementioned, they are renewable supplies and present low toxicity [8]. Furthermore, in the development of new formulations containing essential oils and terpenes, the 12 principles (prevention, atom economy, less hazardous chemical synthesis, designing safer chemicals, safer solvents and auxiliaries, design for energy efficient, use of renewable feedstocks, reduce derivatives, catalysis, design for degradation, real-time analysis for pollution prevention, and inherently safer chemistry for accident prevention) should be respected, since, besides reducing the environmental impact of chemicals, they can also lead to lower costs of production [122], which can balance out investments made in the development and implementation of sustainable alternatives.

4. Concluding Remarks

The interest in the development of nanostructured systems containing essential oils and terpenes designed for topical administration routes has been rising in recent years. The majority of the formulations employ EO and/or terpenes as active ingredients encapsulated in nanostructured systems as means to improve the physicochemical properties and/or achieve greater bioavailability and controlled release of drugs. On the other hand, a part of the studies also shows the growing interest in using terpenes as permeation-enhancer excipients in transdermal delivery systems, a promising strategy for efficient and noninvasive drug delivery to the skin deeper layers.
Terpenes and essential oils present a sustainable alternative as raw materials in the pharmaceutical field and thus a valuable source, giving the growing importance of “greener” chemistry. Many of them are considered GRAS; however, there is a lack of information concerning their safety in topical administration.

Supplementary Materials

The following are available online at https://www.mdpi.com/2218-273X/9/4/138/s1, Table S1: Database search lines.

Author Contributions

Conceptualization—all authors; Data curation—S.P.d.M.; Formal analysis–S.P.d.M. and L.S.K.; Methodology—S.P.d.M. and L.S.K.; Supervision—L.S.K.; Writing—original draft—S.P.d.M. and L.S.K.; Writing—review & editing—all authors.

Funding

This study was financed in part by the “Coordenação de Aperfeiçoamento de Pessoal de Nível Superior–Brasil” (CAPES). Finance Code 001.

Acknowledgments

The authors thank CAPES and CNPq for their scholarships.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Asbahani, A.E.; Miladi, K.; Badri, W.; Sala, M.; Addi, E.H.A.; Casabianca, H.; Mousadik, A.E.; Hartmann, D.; Jilale, A.; Renaud, F.N.R.; et al. Essential oils: From extraction to encapsulation. Int. J. Pharm. 2015, 483, 220–243. [Google Scholar] [CrossRef] [PubMed]
  2. Bilia, A.R.; Guccione, C.; Isacchi, B.; Righeschi, C.; Firenzuoli, F.; Bergonzi, M.C. Essential oils loaded in nanosystems: A developing strategy for a successful therapeutic approach. Evid. Based Complement. Alternat. Med. 2014, 2014. [Google Scholar] [CrossRef] [PubMed]
  3. Majeed, H.; Bian, Y.-Y.; Ali, B.; Jamil, A.; Majeed, U.; Khan, Q.F.; Iqbal, K.J.; Shoemaker, C.F.; Fang, Z. Essential oil encapsulations: Uses, procedures, and trends. RSC Adv. 2015, 5, 58449–58463. [Google Scholar] [CrossRef]
  4. Gershenzon, J.; Dudareva, N. The function of terpene natural products in the natural world. Nat. Chem. Biol. 2007, 3, 408. [Google Scholar] [CrossRef] [PubMed]
  5. Maffei, M.E.; Gertsch, J.; Appendino, G. Plant volatiles: Production, function and pharmacology. Nat. Prod. Rep. 2011, 28, 1359–1380. [Google Scholar] [CrossRef] [PubMed]
  6. Turek, C.; Stintzing, F.C. Stability of Essential Oils: A Review. Compr. Rev. Food Sci. F 2013, 12, 40–53. [Google Scholar] [CrossRef]
  7. Herman, A.; Herman, A.P. Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: A review. J. Pharm. Pharmacol. 2014, 67, 473–485. [Google Scholar] [CrossRef]
  8. Sapra, B.; Jain, S.; Tiwary, A.K. Percutaneous Permeation Enhancement by Terpenes: Mechanistic View. AAPS J. 2008, 10, 120. [Google Scholar] [CrossRef]
  9. Hamm, S.; Bleton, J.; Connan, J.; Tchapla, A. A chemical investigation by headspace SPME and GC–MS of volatile and semi-volatile terpenes in various Olibanum samples. Phytochemistry 2005, 66, 1499–1514. [Google Scholar] [CrossRef]
  10. Pivetta, T.P.; Simões, S.; Araújo, M.M.; Carvalho, T.; Arruda, C.; Marcato, P.D. Development of nanoparticles from natural lipids for topical delivery of thymol: Investigation of its anti-inflammatory properties. Colloids Surf. B Biointerfaces 2018, 164, 281–290. [Google Scholar] [CrossRef]
  11. Takada, H.; Yonekawa, J.; Matsumoto, M.; Furuya, K.; Sokabe, M. Hyperforin/HP-β-Cyclodextrin Enhances Mechanosensitive Ca2+Signaling in HaCaT Keratinocytes and in Atopic Skin Ex Vivo Which Accelerates Wound Healing. Biomed. Res. Int. 2017, 2017, 8701801. [Google Scholar] [CrossRef]
  12. Tosta, F.V.; Andrade, L.M.; Mendes, L.P.; Anjos, J.L.V.; Alonso, A.; Marreto, R.N.; Lima, E.M.; Taveira, S.F. Paclitaxel-loaded lipid nanoparticles for topical application: The influence of oil content on lipid dynamic behavior, stability, and drug skin penetration. J. Nanopart. Res. 2014, 16, 1–12. [Google Scholar] [CrossRef]
  13. Singh, H.; Sharma, R.; Joshi, M.; Garg, T.; Goyal, A.K.; Rath, G. Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers. Artif. Cells Nanomed. Biotechnol. 2015, 43, 263–269. [Google Scholar] [CrossRef]
  14. Bharadwaj, R.; Das, P.J.; Pal, P.; Mazumder, B. Topical delivery of paclitaxel for treatment of skin cancer. Drug Dev. Ind. Pharm. 2016, 42, 1482–1494. [Google Scholar] [CrossRef]
  15. Sinha, V.R.; Kaur, M.P. Permeation Enhancers for Transdermal Drug Delivery. Drug Dev. Ind. Pharm. 2000, 26, 1131–1140. [Google Scholar] [CrossRef]
  16. Scott, R.P.W. ESSENTIAL OILS. In Encyclopedia of Analytical Science, 2nd ed.; Worsfold, P., Townshend, A., Poole, C., Eds.; Elsevier: Oxford, UK, 2005; pp. 554–561. [Google Scholar]
  17. Bhowmik, D.; Gopinath, H.; Kumar, B.P.; Duraivel, S.; Kumar, K.S. Recent advances in novel topical drug delivery system. Pharma Innov. 2012, 1, 12. [Google Scholar]
  18. Brown, M.B.; Martin, G.P.; Jones, S.A.; Akomeah, F.K. Dermal and Transdermal Drug Delivery Systems: Current and Future Prospects. Drug Deliv. 2006, 13, 175–187. [Google Scholar] [CrossRef]
  19. Guilherme, V.A.; Ribeiro, L.N.M.; Tofoli, G.R.; Franz-Montan, M.; de Paula, E.; de Jesus, M.B. Current challenges and future of lipid nanoparticles formulations for topical drug application to oral mucosa, skin, and eye. Curr. Pharm. Des. 2017, 23, 6659–6675. [Google Scholar] [CrossRef]
  20. Sezer, A.D.; Cevher, E. Topical drug delivery using chitosan nano- and microparticles. Expert Opin. Drug Deliv. 2012, 9, 1129–1146. [Google Scholar] [CrossRef]
  21. Bilia, A.R.; Piazzini, V.; Guccione, C.; Risaliti, L.; Asprea, M.; Capecchi, G.; Bergonzi, M.C. Improving on Nature: The Role of Nanomedicine in the Development of Clinical Natural Drugs. Planta Med. 2017, 83, 366–381. [Google Scholar] [CrossRef]
  22. Barua, S.; Mitragotri, S. Challenges associated with penetration of nanoparticles across cell and tissue barriers: A review of current status and future prospects. Nano Today 2014, 9, 223–243. [Google Scholar] [CrossRef]
  23. Lima, P.S.S.; Lucchese, A.M.; Araújo-Filho, H.G.; Menezes, P.P.; Araújo, A.A.S.; Quintans-Júnior, L.J.; Quintans, J.S.S. Inclusion of terpenes in cyclodextrins: Preparation, characterization and pharmacological approaches. Carbohydr. Polym. 2016, 151, 965–987. [Google Scholar] [CrossRef]
  24. Saettone, M.F.; Burgalassi, S.; Giannaccini, B. Preparation and Evaluation in Rabbits of Topical Solutions Containing Forskolin. J. Ocul. Pharmacol. Ther. 1989, 5, 111–118. [Google Scholar] [CrossRef]
  25. El-Nabarawi, M.A.; Shamma, R.N.; Farouk, F.; Nasralla, S.M. Dapsone-Loaded Invasomes as a Potential Treatment of Acne: Preparation, Characterization, and In Vivo Skin Deposition Assay. AAPS PharmSciTech 2018, 19, 2174–2184. [Google Scholar] [CrossRef]
  26. Ahmad, A.; Abuzinadah, M.F.; Alkreathy, H.M.; Banaganapalli, B.; Mujeeb, M. Ursolic acid rich ocimum sanctum L leaf extract loaded nanostructured lipid carriers ameliorate adjuvant induced arthritis in rats by inhibition of COX-1, COX-2, TNF-α and IL-1: Pharmacological and docking studies. PLoS ONE 2018, 13, e0193451. [Google Scholar] [CrossRef]
  27. Abdel-Hafez, S.M.; Hathout, R.M.; Sammour, O.A. Curcumin-loaded ultradeformable nanovesicles as a potential delivery system for breast cancer therapy. Colloids Surf. B Biointerfaces 2018, 167, 63–72. [Google Scholar] [CrossRef]
  28. Cui, Y.; Mo, Y.; Zhang, Q.; Tian, W.; Xue, Y.; Bai, J.; Du, S. Microneedle-Assisted Percutaneous Delivery of Paeoniflorin-Loaded Ethosomes. Molecules 2018, 23, 3371. [Google Scholar] [CrossRef]
  29. Song, K.; Xin, M.; Yu, H.; Zheng, Z.; Li, J.; Li, M.; Guo, H.; Tan, Y.; Wu, X. Novel ultra-small micelles based on rebaudioside A: A potential nanoplatform for ocular drug delivery. Int. J. Pharm. 2018, 552, 265–276. [Google Scholar] [CrossRef]
  30. Sims, K.R.; Liu, Y.; Hwang, G.; Jung, H.I.; Koo, H.; Benoit, D.S.W. Enhanced design and formulation of nanoparticles for anti-biofilm drug delivery. Nanoscale 2019, 11, 219–236. [Google Scholar] [CrossRef]
  31. Abd, E.; Benson, H.A.E.; Roberts, M.S.; Grice, J.E. Follicular Penetration of Caffeine from Topically Applied Nanoemulsion Formulations Containing Penetration Enhancers: In vitro Human Skin Studies. Skin Pharmacol. Physiol. 2018, 31, 252–260. [Google Scholar] [CrossRef]
  32. Nagai, N.; Ogata, F.; Otake, H.; Nakazawa, Y.; Kawasaki, N. Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment. Int. J. Nanomed. 2018, 13, 5215–5229. [Google Scholar] [CrossRef]
  33. Freag, M.S.; Saleh, W.M.; Abdallah, O.Y. Laminated chitosan-based composite sponges for transmucosal delivery of novel protamine-decorated tripterine phytosomes: Ex-vivo mucopenetration and in-vivo pharmacokinetic assessments. Carbohydr. Polym. 2018, 188, 108–120. [Google Scholar] [CrossRef]
  34. Khan, K.; Aqil, M.; Imam, S.S.; Ahad, A.; Moolakkadath, T.; Sultana, Y.; Mujeeb, M. Ursolic acid loaded intra nasal nano lipid vesicles for brain tumour: Formulation, optimization, in-vivo brain/plasma distribution study and histopathological assessment. Biomed. Pharmacother. 2018, 106, 1578–1585. [Google Scholar] [CrossRef]
  35. Bonaccorso, A.; Musumeci, T.; Carbone, C.; Vicari, L.; Lauro, M.R.; Puglisi, G. Revisiting the role of sucrose in PLGA-PEG nanocarrier for potential intranasal delivery. Pharm. Dev. Technol. 2018, 23, 265–274. [Google Scholar] [CrossRef]
  36. Lason, E.; Sikora, E.; Miastkowska, M.; Escribano, E.; Garcia-Celma, M.J.; Solans, C.; Llinas, M.; Ogonowski, J. NLCs as a potential carrier system for transdermal delivery of forskolin. Acta Biochim. Pol. 2018, 65, 437–442. [Google Scholar] [CrossRef]
  37. Wang, J.; Wei, Y.; Fei, Y.R.; Fang, L.; Zheng, H.S.; Mu, C.F.; Li, F.Z.; Zhang, Y.S. Preparation of mixed monoterpenes edge activated PEGylated transfersomes to improve the in vivo transdermal delivery efficiency of sinomenine hydrochloride. Int. J. Pharm. 2017, 533, 266–274. [Google Scholar] [CrossRef]
  38. Zhang, K.; Zhang, Y.; Li, Z.; Li, N.; Feng, N. Essential oil-mediated glycerosomes increase transdermal paeoniflorin delivery: Optimization, characterization, and evaluation in vitro and in vivo. Int. J. Nanomed. 2017, 12, 3521–3532. [Google Scholar] [CrossRef]
  39. Duangjit, S.; Nimcharoenwan, T.; Chomya, N.; Locharoenrat, N.; Ngawhirunpat, T. Computational design strategy: An approach to enhancing the transdermal delivery of optimal capsaicin-loaded transinvasomes. Drug Dev. Ind. Pharm. 2017, 43, 98–107. [Google Scholar] [CrossRef]
  40. Rangsimawong, W.; Obata, Y.; Opanasopit, P.; Ngawhirunpat, T.; Takayama, K. Enhancement of Galantamine HBr Skin Permeation Using Sonophoresis and Limonene-Containing PEGylated Liposomes. AAPS PharmSciTech 2017, 19, 1093–1104. [Google Scholar] [CrossRef]
  41. Yang, M.; Gu, Y.; Yang, D.; Tang, X.; Liu, J. Development of triptolide-nanoemulsion gels for percutaneous administration: Physicochemical, transport, pharmacokinetic and pharmacodynamic characteristics. J. Nanobiotechnol. 2017, 15, 88. [Google Scholar] [CrossRef]
  42. Qadri, G.R.; Ahad, A.; Aqil, M.; Imam, S.S.; Ali, A. Invasomes of isradipine for enhanced transdermal delivery against hypertension: Formulation, characterization, and in vivo pharmacodynamic study. Artif. Cells Nanomed. Biotechnol. 2017, 45, 139–145. [Google Scholar] [CrossRef]
  43. Teixeira, G.F.D.; Vieira-Neto, A.E.; da Costa, F.N.; e Silva, A.R.A.; Campos, A.R. Antinociceptive effect of (-)-α-bisabolol in nanocapsules. Biomed. Pharmacother. 2017, 91, 946–950. [Google Scholar] [CrossRef]
  44. Abdelsamie, S.M.; Kamel, A.O.; Sammour, O.A.; Ibrahim, S.M. Terbinafine hydrochloride nanovesicular gel: In vitro characterization, ex vivo permeation and clinical investigation. Eur. J. Pharm. Sci. 2016, 88, 91–100. [Google Scholar] [CrossRef]
  45. Kamran, M.; Ahad, A.; Aqil, M.; Imam, S.S.; Sultana, Y.; Ali, A. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment. Int. J. Pharm. 2016, 505, 147–158. [Google Scholar] [CrossRef]
  46. Gogoll, K.; Stein, P.; Lee, K.; Arnold, P.; Peters, T.; Schild, H.; Radsak, M.; Langguth, P. Solid nanoemulsion as antigen and immunopotentiator carrier for transcutaneous immunization. Cell. Immunol. 2016, 308, 35–43. [Google Scholar] [CrossRef]
  47. Li, M.; Zhu, L.; Liu, B.; Du, L.; Jia, X.; Han, L.; Jin, Y. Tea tree oil nanoemulsions for inhalation therapies of bacterial and fungal pneumonia. Colloids Surf. B Biointerfaces 2016, 141, 408–416. [Google Scholar] [CrossRef]
  48. Zhu, L.; Liu, X.; Du, L.; Jin, Y. Preparation of asiaticoside-loaded coaxially electrospinning nanofibers and their effect on deep partial-thickness burn injury. Biomed. Pharmacother. 2016, 83, 33–40. [Google Scholar] [CrossRef]
  49. Shen, C.Y.; Xu, P.H.; Shen, B.D.; Min, H.Y.; Li, X.R.; Han, J.; Yuan, H.L. Nanogel for dermal application of the triterpenoids isolated from Ganoderma lucidum (GLT) for frostbite treatment. Drug Deliv. 2016, 23, 610–618. [Google Scholar] [CrossRef]
  50. Ahmad, M.; Rai, S.M.; Mahmood, A. Hydrogel Microparticles as an Emerging Tool in Pharmaceutical Field: A Review. Adv. Polym. Technol. 2016, 35, 121–128. [Google Scholar] [CrossRef]
  51. Jamal, M.; Imam, S.S.; Aqil, M.; Amir, M.; Mir, S.R.; Mujeeb, M. Transdermal potential and anti-arthritic efficacy of ursolic acid from niosomal gel systems. Int. Immunopharmacol. 2015, 29, 361–369. [Google Scholar] [CrossRef]
  52. Horev, B.; Klein, M.I.; Hwang, G.; Li, Y.; Kim, D.; Koo, H.; Benoit, D.S.W. pH-activated Nanoparticles for Controlled Topical Delivery of Farnesol to Disrupt Oral Biofilm Virulence. ACS Nano 2015, 9, 2390–2404. [Google Scholar] [CrossRef]
  53. Alvarado, H.; Abrego, G.; Souto, E.B.; Garduño-Ramirez, M.L.; Clarés, B.; García, M.; Calpena, A. Nanoemulsions for dermal controlled release of oleanolic and ursolic acids: In vitro, ex vivo and in vivo characterization. Colloids Surf. B Biointerfaces 2015, 130, 40–47. [Google Scholar] [CrossRef] [PubMed]
  54. Lu, W.-C.; Chiang, B.-H.; Huang, D.-W.; Li, P.-H. Skin permeation of d-limonene-based nanoemulsions as a transdermal carrier prepared by ultrasonic emulsification. Ultrason. Sonochem. 2014, 21, 826–832. [Google Scholar] [CrossRef]
  55. Rangsimawong, W.; Opanasopit, P.; Rojanarata, T.; Ngawhirunpat, T. Terpene-Containing PEGylated Liposomes as Transdermal Carriers of a Hydrophilic Compound. Boil. Pharm. Bull. 2014, 37, 1936–1943. [Google Scholar] [CrossRef]
  56. Charoenputtakun, P.; Pamornpathomkul, B.; Opanasopit, P.; Rojanarata, T.; Ngawhirunpat, T. Terpene Composited Lipid Nanoparticles for Enhanced Dermal Delivery of All-trans-Retinoic Acids. Boil. Pharm. Bull. 2014, 37, 1139–1148. [Google Scholar] [CrossRef]
  57. Dehelean, C.A.; Feflea, S.; Gheorgheosu, D.; Ganta, S.; Cimpean, A.M.; Muntean, D.; Amiji, M.M. Anti-Angiogenic and Anti-Cancer Evaluation of Betulin Nanoemulsion in Chicken Chorioallantoic Membrane and Skin Carcinoma in Balb/c Mice. J. Biomed. Nanotechnol. 2013, 9, 577–589. [Google Scholar] [CrossRef]
  58. Sandig, A.G.; Campmany, A.C.; Campos, F.F.; Villena, M.M.; Naveros, B.C. Transdermal delivery of imipramine and doxepin from newly oil-in-water nanoemulsions for an analgesic and anti-allodynic activity: Development, characterization and in vivo evaluation. Colloids Surf. B Biointerfaces 2013, 103, 558–565. [Google Scholar] [CrossRef]
  59. Chen, X.; Peng, L.-H.; Shan, Y.-H.; Li, N.; Wei, W.; Yu, L.; Li, Q.-M.; Liang, W.-Q.; Gao, J.-Q. Astragaloside IV-loaded nanoparticle-enriched hydrogel induces wound healing and anti-scar activity through topical delivery. Int. J. Pharm. 2013, 447, 171–181. [Google Scholar] [CrossRef]
  60. Subongkot, T.; Wonglertnirant, N.; Songprakhon, P.; Rojanarata, T.; Opanasopit, P.; Ngawhirunpat, T. Visualization of ultradeformable liposomes penetration pathways and their skin interaction by confocal laser scanning microscopy. Int. J. Pharm. 2013, 441, 151–161. [Google Scholar] [CrossRef]
  61. Barros, N.B.; Migliaccio, V.; Facundo, V.A.; Ciancaglini, P.; Stabeli, R.G.; Nicolete, R.; Silva-Jardim, I. Liposomal-lupane system as alternative chemotherapy against cutaneous leishmaniasis: Macrophage as target cell. Exp. Parasitol. 2013, 135, 337–343. [Google Scholar] [CrossRef]
  62. Patel, P.A.; Patil, S.C.; Kalaria, D.R.; Kalia, Y.N.; Patravale, V.B. Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A. Int. J. Pharm. 2013, 446, 16–23. [Google Scholar] [CrossRef]
  63. Chen, Y.; Zhou, L.; Yuan, L.; Zhang, Z.-H.; Liu, X.; Wu, Q. Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers. Int. J. Nanomed. 2012, 7, 3023–3033. [Google Scholar]
  64. Paolino, D.; Cosco, D.; Cilurzo, F.; Trapasso, E.; Morittu, V.M.; Celia, C.; Fresta, M. Improved in vitro and in vivo collagen biosynthesis by asiaticoside-loaded ultradeformable vesicles. J. Control. 2012, 162, 143–151. [Google Scholar] [CrossRef] [PubMed]
  65. Chen, J.-G.; Liu, Y.-F.; Gao, T.-W. Preparation and anti-inflammatory activity of triptolide ethosomes in an erythema model. J. Liposome Res. 2010, 20, 297–303. [Google Scholar] [CrossRef]
  66. Fang, J.-Y. Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int. J. Nanomed. 2010, 5, 117. [Google Scholar] [CrossRef]
  67. Mura, S.; Manconi, M.; Sinico, C.; Valenti, D.; Fadda, A.M. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int. J. Pharm. 2009, 380, 72–79. [Google Scholar] [CrossRef]
  68. Dragicevic-Curic, N.; Gräfe, S.; Albrecht, V.; Fahr, A. Topical application of temoporfin-loaded invasomes for photodynamic therapy of subcutaneously implanted tumours in mice: A pilot study. J. Photochem. Photobiol. B Boil. 2008, 91, 41–50. [Google Scholar] [CrossRef]
  69. Dragicevic-Curic, N.; Scheglmann, D.; Albrecht, V.; Fahr, A. Temoporfin-loaded invasomes: Development, characterization and in vitro skin penetration studies. J. Control. 2008, 127, 59–69. [Google Scholar] [CrossRef]
  70. Dragicevic-Curic, N.; Scheglmann, D.; Albrecht, V.; Fahr, A. Development of different temoporfin-loaded invasomes—Novel nanocarriers of temoporfin: Characterization, stability and in vitro skin penetration studies. Colloids Surf. B Biointerfaces 2009, 70, 198–206. [Google Scholar] [CrossRef]
  71. Mei, Z.; Wu, Q.; Hu, S.; Lib, X.; Yang, X. Triptolide Loaded Solid Lipid Nanoparticle Hydrogel for Topical Application. Drug Dev. Ind. Pharm. 2005, 31, 161–168. [Google Scholar] [CrossRef]
  72. Rode, T. Complex formation of sericoside with hydrophilic cyclodextrins: Improvement of solubility and skin penetration in topical emulsion-based formulations. Eur. J. Pharm. Biopharm. 2003, 55, 191–198. [Google Scholar] [CrossRef]
  73. Mei, Z. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur. J. Pharm. Biopharm. 2003, 56, 189–196. [Google Scholar] [CrossRef]
  74. Afifah, S.N.; Azhar, S.; Ashari, S.E.; Salim, N. Development of a kojic monooleate-enriched oil-in-water nanoemulsion as a potential carrier for hyperpigmentation treatment. Int. J. Nanomed. 2018, 13, 6465–6479. [Google Scholar]
  75. Barradas, T.N.; Senna, J.P.; Cardoso, S.A.; Silva, K.G.D.E.; Mansur, C.R.E. Formulation characterization and in vitro drug release of hydrogel-thickened nanoemulsions for topical delivery of 8-methoxypsoralen. Mater. Sci. Eng. C Mater. Biol. Appl. 2018, 92, 245–253. [Google Scholar] [CrossRef] [PubMed]
  76. Oliveira, C.A.; Gouvêa, M.M.; Antunes, G.R.; Freitas, Z.M.F.; Marques, F.F.C.; Ricci-Junior, E. Nanoemulsion containing 8-methoxypsoralen for topical treatment of dermatoses: Development, characterization and ex vivo permeation in porcine skin. Int. J. Pharm. 2018, 547, 1–9. [Google Scholar] [CrossRef] [PubMed]
  77. Srivastava, N.; Patel, D.K.; Rai, V.K.; Pal, A.; Yadav, N.P. Development of Emulgel formulation for vaginal candidiasis: Pharmaceutical characterization, in vitro and in vivo evaluation. J. Drug Deliv. Sci. Technol. 2018, 48, 490–498. [Google Scholar] [CrossRef]
  78. Alotaibi, F.O.; Mustafa, G.; Ahuja, A. Study of Enhanced Anti-Inflammatory Potential of Nigella Sativa in Topical Nanoformulation. Int. J. Pharm. Pharm. Sci. 2018, 10, 41. [Google Scholar] [CrossRef]
  79. Barradas, T.N.; Senna, J.P.; Cardoso, S.A.; Nicoli, S.; Padula, C.; Santi, P.; Rossi, F.; Silva, K.G.D.E.; Mansur, C.R.E. Hydrogel-thickened nanoemulsions based on essential oils for topical delivery of psoralen: Permeation and stability studies. Eur. J. Pharm. Biopharm. 2017, 116, 38–50. [Google Scholar] [CrossRef]
  80. Kalita, S.; Kandimalla, R.; Devi, B.; Kalita, B.; Kalita, K.; Deka, M.; Kataki, A.C.; Sharma, A.; Kotoky, J. Dual delivery of chloramphenicol and essential oil by poly-ε-caprolactone-Pluronic nanocapsules to treat MRSA-Candida co-infected chronic burn wounds. RSC Adv. 2017, 7, 1749–1758. [Google Scholar] [CrossRef]
  81. Montenegro, L.; Pasquinucci, L.; Zappalà, A.; Chiechio, S.; Turnaturi, R.; Parenti, C. Rosemary Essential Oil-Loaded Lipid Nanoparticles: In Vivo Topical Activity from Gel Vehicles. Pharmaceutics 2017, 9, 48. [Google Scholar] [CrossRef]
  82. Navayan, A.; Moghimipour, E.; Khodayar, M.J.; Vazirianzadeh, B.; Siahpoosh, A.; Valizadeh, M.; Mansourzadeh, Z. Evaluation of the Mosquito Repellent Activity of Nano-sized Microemulsion of Eucalyptus globulus Essential Oil Against Culicinae. Jundishapur J. Nat. Pharm. Prod. 2017, 12. [Google Scholar] [CrossRef]
  83. Alam, P.; Ansari, M.J.; Anwer, M.K.; Raish, M.; Kamal, Y.K.T.; Shakeel, F. Wound healing effects of nanoemulsion containing clove essential oil. Artif. Cells Nanomed. Biotechnol. 2017, 45, 591–597. [Google Scholar] [CrossRef] [PubMed]
  84. Sinha, P.; Srivastava, S.; Mishra, N.; Singh, D.K.; Luqman, S.; Chanda, D.; Yadav, N.P. Development, optimization, and characterization of a novel tea tree oil nanogel using response surface methodology. Drug Dev. Ind. Pharm. 2016, 42, 1–12. [Google Scholar] [CrossRef] [PubMed]
  85. Sawatdee, S.; Choochuay, K.; Chanthorn, W.; Srichana, T. Evaluation of the topical spray containing Centella asiatica extract and its efficacy on excision wounds in rats. Acta Pharm. 2016, 66, 233–244. [Google Scholar] [CrossRef]
  86. Botelho, M.A.; Barros, G.; Queiroz, D.B.; Carvalho, C.F.; Gouvea, J.; Patrus, L.; Bannet, M.; Patrus, D.; Rego, A.; Silva, I.; et al. Nanotechnology in Phytotherapy: Antiinflammatory Effect of a Nanostructured Thymol Gel from Lippia sidoides in Acute Periodontitis in Rats. Phytother. Res. 2016, 30, 152–159. [Google Scholar] [CrossRef] [PubMed]
  87. Mostafa, D.M.; El-Alim, S.H.A.; Asfour, M.H.; Al-Okbi, S.Y.; Mohamed, D.A.; Awad, G.; El-Alim, S.A. Transdermal nanoemulsions of Foeniculum vulgare Mill. essential oil: Preparation, characterization and evaluation of antidiabetic potential. J. Drug Deliv. Sci. Technol. 2015, 29, 99–106. [Google Scholar] [CrossRef]
  88. Aldawsari, H.M.; Badr-Eldin, S.M.; Labib, G.S.; El-Kamel, A.H. Design and formulation of a topical hydrogel integrating lemongrass-loaded nanosponges with an enhanced antifungal effect: In vitro/in vivo evaluation. Int. J. Nanomed. 2015, 10, 893–902. [Google Scholar]
  89. Lucca, L.G.; De Matos, S.P.; Borille, B.T.; Dias, D.D.O.; Teixeira, H.F.; Veiga, V.F.; Limberger, R.P.; Koester, L.S. Determination of β-caryophyllene skin permeation/retention from crude copaiba oil (Copaifera multijuga Hayne) and respective oil-based nanoemulsion using a novel HS-GC/MS method. J. Pharm. Biomed. Anal. 2015, 104, 144–148. [Google Scholar] [CrossRef]
  90. Castangia, I.; Manca, M.L.; Caddeo, C.; Maxia, A.; Murgia, S.; Pons, R.; Demurtas, D.; Pando, D.; Falconieri, D.; Peris, J.E.; et al. Faceted phospholipid vesicles tailored for the delivery of Santolina insularis essential oil to the skin. Colloids Surf. B Biointerfaces 2015, 132, 185–193. [Google Scholar] [CrossRef]
  91. Flores, F.C.; de Lima, J.A.; da Silva, C.R.; Benvegnú, D.; Ferreira, J.; Burger, M.E.; Beck, R.C.R.; Rolim, C.M.B.; Rocha, M.I.U.M.; da Veiga, M.L.; et al. Hydrogels Containing Nanocapsules and Nanoemulsions of Tea Tree Oil Provide Antiedematogenic Effect and Improved Skin Wound Healing. J. Nanosci. Nanotechnol. 2015, 15, 800–809. [Google Scholar] [CrossRef]
  92. Sugumar, S.; Ghosh, V.; Nirmala, M.J.; Mukherjee, A.; Chandrasekaran, N. Ultrasonic emulsification of eucalyptus oil nanoemulsion: Antibacterial activity against Staphylococcus aureus and wound healing activity in Wistar rats. Ultrason. Sonochem. 2014, 21, 1044–1049. [Google Scholar] [CrossRef] [PubMed]
  93. Tonglairoum, P.; Chuchote, T.; Ngawhirunpat, T.; Rojanarata, T.; Opanasopit, P. Encapsulation of plai oil/2-hydroxypropyl-β-cyclodextrin inclusion complexes in polyvinylpyrrolidone (PVP) electrospun nanofibers for topical application. Pharm. Dev. Technol. 2014, 19, 430–437. [Google Scholar] [CrossRef] [PubMed]
  94. Danielli, L.J.; Dos Reis, M.; Bianchini, M.; Camargo, G.S.; Bordignon, S.A.; Guerreiro, I.K.; Fuentefria, A.; Apel, M.A. Antidermatophytic activity of volatile oil and nanoemulsion of Stenachaenium megapotamicum (Spreng.) Baker. Ind. Crop. Prod. 2013, 50, 23–28. [Google Scholar] [CrossRef]
  95. Ortan, A.; Ferdes, M.; Rodino, S.; Pirvu, C.D.; Draganescu, D. Liposomally encapsulated volatile oil of Anethum graveolens. Farmacia 2013, 61, 361–370. [Google Scholar]
  96. Flores, F.C.; Lima, J.A.; Ribeiro, R.F.; Alves, S.H.; Rolim, C.M.B.; Beck, R.C.R.; Silva, C.B.; De Lima, J.A.; Da Silva, C.B. Antifungal Activity of Nanocapsule Suspensions Containing Tea Tree Oil on the Growth of Trichophyton rubrum. Mycopathologia 2013, 175, 281–286. [Google Scholar] [CrossRef] [PubMed]
  97. Dias, D.D.O.; Colombo, M.; Kelmann, R.G.; De Souza, T.P.; Bassani, V.L.; Teixeira, H.F.; Veiga, V.F., Jr.; Limberger, R.P.; Koester, L.S. Optimization of headspace solid-phase microextraction for analysis of β-caryophyllene in a nanoemulsion dosage form prepared with copaiba (Copaifera multijuga Hayne) oil. Anal. Chim. 2012, 721, 79–84. [Google Scholar] [CrossRef] [PubMed]
  98. Ali, M.S.; Alam, M.S.; Imam, F.I.; Siddiqui, M.R. Topical nanoemulsion of turmeric oil for psoriasis: Characterization, ex vivo and in vivo assessment. Int. J. Drug Deliv. 2012, 4. [Google Scholar] [CrossRef]
  99. Sakulku, U.; Nuchuchua, O.; Uawongyart, N.; Puttipipatkhachorn, S.; Soottitantawat, A.; Ruktanonchai, U. Characterization and mosquito repellent activity of citronella oil nanoemulsion. Int. J. Pharm. 2009, 372, 105–111. [Google Scholar] [CrossRef]
  100. Lai, F.; Sinico, C.; De Logu, A.; Zaru, M.; Müller, R.H.; Fadda, A.M. SLN as a topical delivery system for Artemisia arborescens essential oil: In vitro antiviral activity and skin permeation study. Int. J. Nanomed. 2007, 2, 419–425. [Google Scholar]
  101. Suslina, S.N.; Alekseev, K.V.; Starodubova, M.V.; Bagirova, V.L. Drug synthesis methods and manufacturing technology: Development and comparative evaluation of a new liposomal dermatological preparation based on Viton oil. Pharm. Chem. J. 2004, 38, 492–497. [Google Scholar] [CrossRef]
  102. Heather, A.E.B. Transdermal Drug Delivery: Penetration Enhancement Techniques. Curr. Drug Deliv. 2005, 2, 23–33. [Google Scholar]
  103. Schnitzler, P.; Suschke, U.; Reichling, J.; Saller, R. Essential Oils of Aromatic Plants with Antibacterial, Antifungal, Antiviral, and Cytotoxic Properties—An Overview. Complement. Med. Res. 2009, 16, 79–90. [Google Scholar]
  104. De Matos, S.P.; Lucca, L.G.; Koester, L.S. Essential oils in nanostructured systems: Challenges in preparation and analytical methods. Talanta 2019, 195, 204–214. [Google Scholar] [CrossRef] [PubMed]
  105. Li, Z.; Liu, M.; Wang, H.; Du, S. Increased cutaneous wound healing effect of biodegradable liposomes containing madecassoside: Preparation optimization, in vitro dermal permeation, and in vivo bioevaluation. Int. J. Nanomed. 2016, 11, 2995–3007. [Google Scholar] [CrossRef] [PubMed]
  106. Lohani, A.; Verma, A. Vesicles: Potential nano carriers for the delivery of skin cosmetics. J. Cosmet. Ther. 2017, 19, 485–493. [Google Scholar] [CrossRef] [PubMed]
  107. Conte, R.; Marturano, V.; Peluso, G.; Calarco, A.; Cerruti, P.; Andrade, P.; Valentão, P. Recent Advances in Nanoparticle-Mediated Delivery of Anti-Inflammatory Phytocompounds. Int. J. Mol. Sci. 2017, 18, 709. [Google Scholar] [CrossRef]
  108. Cal, K.; Centkowska, K. Use of cyclodextrins in topical formulations: Practical aspects. Eur. J. Pharm. Biopharm. 2008, 68, 467–478. [Google Scholar] [CrossRef]
  109. Wadhwa, G.; Kumar, S.; Chhabra, L.; Mahant, S.; Rao, R. Essential oil–cyclodextrin complexes: An updated review. J. Incl. Phenom. Macrocycl. Chem. 2017, 89, 39–58. [Google Scholar] [CrossRef]
  110. Marques, H.M.C. A review on cyclodextrin encapsulation of essential oils and volatiles. Flavour Fragr. J. 2010, 25, 313–326. [Google Scholar] [CrossRef]
  111. Mura, S.; Manconi, M.; Fadda, A.M.; Sala, M.C.; Perricci, J.; Pini, E.; Sinico, C. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil: In vitro evaluation of drug permeation by infrared spectroscopy. Pharm. Dev. Technol. 2013, 18, 1339–1345. [Google Scholar] [CrossRef]
  112. Fox, L.T.; Gerber, M.; Du Plessis, J.; Hamman, J.H. Transdermal Drug Delivery Enhancement by Compounds of Natural Origin. Molecules 2011, 16, 10507–10540. [Google Scholar] [CrossRef]
  113. Sinico, C.; Fadda, A.M. Vesicular carriers for dermal drug delivery. Opin. Drug Deliv. 2009, 6, 813–825. [Google Scholar] [CrossRef] [PubMed]
  114. Lalko, J.; Api, A. Investigation of the dermal sensitization potential of various essential oils in the local lymph node assay. Chem. Toxicol. 2006, 44, 739–746. [Google Scholar] [CrossRef] [PubMed]
  115. Aqil, M.; Ahad, A.; Sultana, Y.; Ali, A.; Aqil, M. Status of terpenes as skin penetration enhancers. Drug Discov. 2007, 12, 1061–1067. [Google Scholar] [CrossRef] [PubMed]
  116. Koul, O. Essential Oils as Green Pesticides: Potential and Constraints. Biopestic. Int. 2008, 4, 63–84. [Google Scholar]
  117. Tanzi, C.D.; Vian, M.A.; Giniès, C.; Elmaataoui, M.; Chemat, F. Terpenes as Green Solvents for Extraction of Oil from Microalgae. Molecules 2012, 17, 8196–8205. [Google Scholar] [CrossRef]
  118. Marturano, V.; Bizzarro, V.; De Luise, A.; Calarco, A.; Ambrogi, V.; Giamberini, M.; Tylkowski, B.; Cerruti, P. Essential oils as solvents and core materials for the preparation of photo-responsive polymer nanocapsules. Nano Res. 2018, 11, 2783–2795. [Google Scholar] [CrossRef]
  119. Mashwani, Z.-U.-R.; Khan, M.A.; Khan, T.; Nadhman, A. Applications of plant terpenoids in the synthesis of colloidal silver nanoparticles. Adv. Sci. 2016, 234, 132–141. [Google Scholar] [CrossRef]
  120. Périno-Issartier, S.; Giniès, C.; Cravotto, G.; Chemat, F. A comparison of essential oils obtained from lavandin via different extraction processes: Ultrasound, microwave, turbohydrodistillation, steam and hydrodistillation. J. Chromatogr. A 2013, 1305, 41–47. [Google Scholar] [CrossRef]
  121. Anastas, P.T.; Kirchhoff, M.M. Origins, Current Status, and Future Challenges of Green Chemistry. Acc. Chem. Res. 2002, 35, 686–694. [Google Scholar] [CrossRef]
  122. Tucker, J.L. Green Chemistry, a Pharmaceutical Perspective. Org. Process. Res. Dev. 2006, 10, 315–319. [Google Scholar] [CrossRef]
Biomolecules 09 00138 g001 550
Figure 1. Flowchart representing the steps of literature survey and selection of research papers.
Figure 1. Flowchart representing the steps of literature survey and selection of research papers.
Biomolecules 09 00138 g001
Biomolecules 09 00138 g002 550
Figure 2. Annual distribution of publications.
Figure 2. Annual distribution of publications.
Biomolecules 09 00138 g002
Biomolecules 09 00138 g003 550
Figure 3. Topical administration routes of nanoencapsulated essential oils (EO) containing terpenes and isolated terpenes.
Figure 3. Topical administration routes of nanoencapsulated essential oils (EO) containing terpenes and isolated terpenes.
Biomolecules 09 00138 g003
Biomolecules 09 00138 g004 550
Figure 4. Application of EO/terpenes as excipients or bioactive ingredients in formulations.
Figure 4. Application of EO/terpenes as excipients or bioactive ingredients in formulations.
Biomolecules 09 00138 g004
Biomolecules 09 00138 g005 550
Figure 5. Nanostructured systems used in the encapsulation of essential oils containing terpenes and isolated terpenes as bioactive compounds for topical formulations. LS, liposomes, VS, vesicular systems, SLN, solid lipid nanoparticles, NLC, nanostructured lipid carriers, NE, nanoemulsions, NC, nanocapsules.
Figure 5. Nanostructured systems used in the encapsulation of essential oils containing terpenes and isolated terpenes as bioactive compounds for topical formulations. LS, liposomes, VS, vesicular systems, SLN, solid lipid nanoparticles, NLC, nanostructured lipid carriers, NE, nanoemulsions, NC, nanocapsules.
Biomolecules 09 00138 g005
Biomolecules 09 00138 g006 550
Figure 6. Nanostructured systems used in formulations containing essential oils and/or isolated terpenes excipients for topical administration. IV: invasomes, PEV: permeation-enhancing vehicles.
Figure 6. Nanostructured systems used in formulations containing essential oils and/or isolated terpenes excipients for topical administration. IV: invasomes, PEV: permeation-enhancing vehicles.
Biomolecules 09 00138 g006
Biomolecules 09 00138 g007 550
Figure 7. Monoterpenes used as permeation enhancers in nanostructured systems.
Figure 7. Monoterpenes used as permeation enhancers in nanostructured systems.
Biomolecules 09 00138 g007
Table
Table 1. Publications found in the literature concerning the encapsulation of isolated terpenes in nanostructured systems intended for topical administration.
Table 1. Publications found in the literature concerning the encapsulation of isolated terpenes in nanostructured systems intended for topical administration.
YearTerpeneSystemAdministration RouteBiological ActivityTerpene Role in the Nanosystem
[25]2018Limonene, cineole, fenchone, and citralInvasomesCutaneousAnti-acneExcipient
[26]2018Ursolic acidSolid lipid nanoparticlesCutaneousAntiarthriticBioactive
[27]2018LimoneneNanovesiclesTransdermalAntineoplasticExcipient
[28]2018PaeoniflorinEthosomesTransdermalAntiarthriticBioactive
[29]2018Rebaudioside AUltra-small micellesOcularNAExcipient
[30]2018FarnesolNanoparticlesOralAntibiofilmBioactive
[31]2018EucaliptolNanoemulsionTransfollicularNAExcipient
[32]2018MentholNanoparticlesTransdermalOsteoporosis treatmentExcipient
[33]2018TripterinePhytosomesOralAntineoplasticBioactive
[34]2018Ursolic acid and anetholeLiposomesNasalAntineoplasticBioactive and excipient
[10]2018ThymolSolid lipid nanoparticlesCutaneousAnti-inflammatoryBioactive
[35]2018DocetaxelPolymeric nanoparticlesNasalAntineoplasticBioactive
[36]2018ForskolinNanostructures lipid carriersTransdermalPhotoprotectorBioactive
[37]2017Citral and limoneneTransferosomes and liposomesTransdermalAntiarthriticExcipient
[38]2017PaeoniflorinGlycerosomesTransdermalAnti-inflammatoryBioactive and Excipient
[39]2017LimoneneTransinvasomesTransdermalNAExcipient
[40]2017LimonenePEGylated liposomesTransdermalAlzheimer’s treatmentExcipient
[41]2017TriptolideNanoemulsionPercutaneousAnti-inflammatory and analgesicBioactive
[42]2017β-citronelleneInvasomesTransdermalHypertension treatmentExcipient
[43]2017α-bisabololNanocapsulesOcularAntinociceptiveBioactive
[11]2017HyperforinHydroxypropyl-β-cyclodextrinCutaneousWound healingBioactive
[44]2016Cineole and limonenePenetration enhancer vehicleTransdermalAntifungalExcipient
[45]2016β-citronelleneInvasomesTransdermalHypertension treatmentExcipient
[46]2016SqualeneSolid nanoemulsionTransdermalImmunizationExcipient
[14]2016PaclitaxelSolid Lipid NanoparticlesCutaneousAntineoplasticBioactive
[47]2016MadecassosideLiposomesCutaneousWound healingBioactive
[48]2016AsiaticosideNanofibersCutaneousWound healingBioactive
[49]2016Triterpenoids of Ganoderma l.NanogelCutaneousFrostbite treatmentBioactive
[50]2016SafranalNanoemulsionNasalCerebral ischemia treatmentBioactive
[51]2015Ursolic acidNiosomal gelTransdermalAntiarthriticBioactive
[52]2015FarnesolPolymeric nanoparticlesOralAntibiofilmBioactive
[53]2015Ursolic acid and oleanoic acidNanoemulsionCutaneousAnti-inflammatoryBioactive
[13]2015DocetaxelNanofibersCutaneousAntineoplasticBioactive
[54]2014LimoneneNanoemulsionTransdermalNAExcipient
[55]2014LimonenoPEGilated liposomesTransdermalNAExcipient
[56]2014Limonene and 1,8-cineoleNanoemulsion and solid lipid nanoparticles and nanostructures lipid carriersCutaneousCutaneous lesions treatmentExcipient
[12]2014PaclitaxelSolid lipid nanoparticles and Nanostructures lipid carriersCutaneousHyperkeratosis treatmentBioactive
[57]2013BetulinNanoemulsionCutaneousAntineoplasticBioactive
[58]2013LimoneneNanoemulsionTransdermalAnalgesicExcipient
[59]2013Astragaloside IVSolid lipid nanoparticlesCutaneousWound healingBioactive
[60]2013LimoneneLiposomesTransdermalNAExcipient
[61]2013LupaneLiposomesCutaneousLeishmanicidalBioactive
[62]2013Hurpezine ASolid lipid nanoparticles, Nanostructures lipid carriers and MicroemulsionTransdermalAlzheimer’s treatmentBioactive
[63]2012TripterineNanostructures lipid carriersCutaneousAntineoplasticBioactive
[64]2012AsiaticosideLiposomesTransdermalStimulation of collagen synthesisBioactive
[65]2010TriptolideEthosomesTransdermalAnti-inflammatoryBioactive
[66]2010SqualeneNanostructures lipid carriersCutaneousPsoriasis treatmentExcipient
[67]2009CineolePenetration enhancer vehicleTransdermalAlopecia treatmentExcipient
[68,69,70]2009, 2008Limonene, citral and cineoleInvasomesTransdermalPhotosensitizationExcipient
[71]2005TriptolideSolid lipid nanoparticlesCutaneousAnti-inflammatoryBioactive
[72]2003Sericosidederivates of β- and γ-cyclodextrinsCutaneousAnti-inflammatoryBioactive
[73]2003TriptolideSolid lipid nanoparticlesCutaneousAnti-inflammatoryBioactive
[24]1989Forskolinβ- and γ-cyclodextrinsOcularTreatment of intraocular hypertensionBioactive
NA: not applicable.
Table
Table 2. Publications found in the literature concerning the encapsulation of essential oils, fixed oils, and plant extract containing terpenes in nanostructured systems intended for topical administration.
Table 2. Publications found in the literature concerning the encapsulation of essential oils, fixed oils, and plant extract containing terpenes in nanostructured systems intended for topical administration.
YearEssential Oil/Fixed Oil/Plant ExtractSystemAdministration RouteBiological ActivityEssential Oil/Fixed Oil/Plant Extract Role in the System
[74]2018Lemon EONanoemulsionCutaneousHyperpigmentation treatmentExcipient
[75]2018Clove EO and sweet fennel EONanoemulsionCutaneousAutoimmune dermatosesExcipient
[76]2018Clove EO and sweet fennel EONanoemulsionCutaneousAutoimmune dermatosesExcipient
[77]2018Mentha EONanogelVaginalAntifungalBioactive
[78]2018Nigella Sativa EONanoemulsionsCutaneousAnti-inflammatoryBioactive
[79]2017Clove EO and Sweet Fennel EONanoemulsionTransdermalAutoimmune dermatosesExcipient
[80]2017Cymbopogon Flexuous EONanocapsulesCutaneousAntimicrobialBioactive
[81]2017Rosemary EOLipid NanoparticlesCutaneousSkin hydrationBioactive
[82]2017Eucaliptus globulosus EONanosized-microemulsionCutaneousRepellentBioactive
[83]2017Syzygium aromaticum EONanoemulsionCutaneousWound healing and antidermatophyticBioactive
[84]2016Tea Tree OilNanoemulsionCutaneousAntimicrobialBioactive
[85]2016Centella asiatica extractHydroxypropyl-β-cyclodextrinCutaneousWound healingBioactive
[86]2016Lippia sidoides EONanogelOralPeriodontitis treatmentBioactive
[87]2015Foeniculum vulgare EONanoemulsionTransdermalAntidiabeticBioactive
[88]2015Lemongrass oilNanospongesCutaneousAntifungalBioactive
[89]2015Copaifera multijuga EONanoemulsionPercutaneousAnti-inflammatoryBioactive
[90]2015Santolina insularis EOPenetration enhancing vehiclePercutaneousAntimicrobialBioactive and excipient
[91]2015Melaleuca alternifolia EONanoemulsion and NanocapsulesCutaneousWound healing and antidermatotophyticBioactive
[92]2014Eucalyptus oilNanoemulsionCutaneousAntibacterial and Wound healingBioactive
[93]2014Plai oilHydroxypropyl-β-cyclodextrin and NanofibersCutaneousAnti-inflammatoryBioactive
[94]2013Stenachaenium megapotamicum EONanoemulsionCutaneousAntidermatophyticBioactive
[95]2013Anethum graveolens EOLiposomesCutaneousAntifungalBioactive
[96]2013M. alternifolia EONanoemulsion and nanocapsulesUnguealOnychomycosis treatmentBioactive
[97]2012C. multijuga EONanoemulsionPercutaneousAnti-inflammatoryBioactive
[98]2012Turmeric oilNanoemulsionCutaneousPsoriasis treatmentBioactive
[99]2009Citronella oilNanoemulsionCutaneousRepellentBioactive
[100]2007Artemisia arborescens EOSolid Lipid NanoparticlesCutaneousAntiviralBioactive
[101]2004Viton oilLiposomesCutaneousAnti-inflammatoryBioactive

Share and Cite

MDPI and ACS Style

de Matos, S.P.; Teixeira, H.F.; de Lima, Á.A.N.; Veiga-Junior, V.F.; Koester, L.S. Essential Oils and Isolated Terpenes in Nanosystems Designed for Topical Administration: A Review. Biomolecules 2019, 9, 138. https://doi.org/10.3390/biom9040138

AMA Style

de Matos SP, Teixeira HF, de Lima ÁAN, Veiga-Junior VF, Koester LS. Essential Oils and Isolated Terpenes in Nanosystems Designed for Topical Administration: A Review. Biomolecules. 2019; 9(4):138. https://doi.org/10.3390/biom9040138

Chicago/Turabian Style

de Matos, Sheila P., Helder F. Teixeira, Ádley A. N. de Lima, Valdir F. Veiga-Junior, and Letícia S. Koester. 2019. "Essential Oils and Isolated Terpenes in Nanosystems Designed for Topical Administration: A Review" Biomolecules 9, no. 4: 138. https://doi.org/10.3390/biom9040138

APA Style

de Matos, S. P., Teixeira, H. F., de Lima, Á. A. N., Veiga-Junior, V. F., & Koester, L. S. (2019). Essential Oils and Isolated Terpenes in Nanosystems Designed for Topical Administration: A Review. Biomolecules, 9(4), 138. https://doi.org/10.3390/biom9040138

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop